Biotech and Biomed Researchers to Benefit from Imaging Companies Merger

The integration of two highly regarded manufacturers of imaging and microscopy systems is designed to provide scientists and clinicians in the biomedical and biotechnical fields with the best options for imaging and intelligent image analysis.

The actors in this endeavor are Leica Microsystems (Wetzlar, Germany), which has acquired Genetix Ltd. (New Milton, United Kingdom).

Leica Microsystems is a leading global designer and producer of innovative, high technology, precision optical systems for the analysis of microstructures. It is a market leader in the fields of microscopy, confocal laser scanning microscopy, and corresponding imaging systems, specimen preparation and medical equipment.

Genetix has established industry standards in areas such as picking microbial colonies for genomic studies or screening and selection of mammalian cell lines. Other Genetix systems use imaging platforms to monitor cell growth, evaluate cellular response, and quantify tissue biomarkers. Genetix will exist as a separate business unit within Leica Microsystems and will continue to market its products through existing channels. Customer services such as product ordering, applications support, and instrument service will remain unchanged.

Stefan Traeger, managing director of the life science division at Leica Microsystems, said, "Genetix's extensive expertise will be invaluable for us. Their software capabilities, specifically in analytical software, will help us to make progress in the area of virtual microscopy, which is a field we have only recently stepped into. In addition, Genetix's experience and market leading products in cell biology and genetics will expand our reach into the drug discovery and development markets.”

Charles de Rohan, head of the Genetix business unit within Leica Microsystems, said,
"Joining together with Leica Microsystems gives Genetix greater access to global markets and increased financial resources to achieve its growth plans. Over the past decade, Genetix has been building its presence in the life sciences, diagnostics, and digital pathology segments through a combination of internal product development and acquisitions. Combining our strengthening presence with Leica Microsystems' R&D capabilities, greater resources, and global reach is in the best interests of our shareholders, customers, and employees and will maximize the potential of our innovative technology.”

Related Links:
Leica Microsystems
Genetix Ltd.